# Study Descriptions

Amount of assay data provided from each study

| study                                                                                                                                                                                 | aggregation | binding | expression | immunogenicity | pharmacokinetics | polyreactivity | thermostability |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------- | ------- | ---------- | -------------- | ---------------- | -------------- | --------------- | 
| [Biophysical properties of the clinical-stage antibody landscape](https://doi.org/10.1073/pnas.1616408114)                                                                            |   685       |         |    137     |                |                  |      685       |       137       |
| [Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows](https://doi.org/10.1080/19420862.2024.2384104)                 |   301       |   33    |            |                |       86         |      86        |       43        | 
| [Homology modeling and structure-based design improve hydrophobic interaction chromatography behavior of integrin binding antibodies](https://doi.org/10.1080/19420862.2018.1475871)  |    97       |         |            |                |                  |                |                 |  
| [Heparin chromatography as an in vitro predictor for antibody clearance rate through pinocytosis](https://doi.org/10.1080/19420862.2019.1683432)                                      |    128      |         |            |                |                  |                |                 |  
| [Unlocking de novo antibody design with generative artificial intelligence](https://doi.org/10.1101/2023.01.08.523187)                                                                |    65       |   461   |            |                |       39         |       26       |       39        |  
| [Machine learning optimization of candidate antibody yields highly diverse sub-nanomolar affinity antibody libraries](https://doi.org/10.1038/s41467-023-39022-2)                     |             |3,163,629|            |                |                  |                |                 |  
| [AbRank: A Benchmark Dataset and Metric-Learning Framework for Antibody-Antigen Affinity Ranking](https://doi.org/10.48550/arXiv.2506.17857)                                          |             | 342,357 |            |                |                  |                |                 |  
| [Measuring the sequence-affinity landscape of antibodies with massively parallel titration curves](https://doi.org/10.7554/eLife.23156)                                               |             |  11,067 |  10,970    |                |                  |                |                 |  
| [A dataset comprised of binding interactions for 104,972 antibodies against a SARS-CoV-2 peptide](https://doi.org/10.1038/s41597-022-01779-4)                                         |             | 352,140 |            |                |                  |                |                 |   
| [Efficient evolution of human antibodies from general protein language models](https://doi.org/10.1038/s41587-023-01763-2)                                                            |             |   146   |            |                |                  |                |       37        |   
| [Toward enhancement of antibody thermostability and affinity by computational design in the absence of antigen](https://doi.org/10.1080/19420862.2024.2362775)                        |             |  362    |            |                |                  |                |       258       |   
| [Retrospective SARS-CoV-2 human antibody development trajectories are largely sparse and permissive](https://doi.org/10.1073/pnas.2412787122)                                         |             |  2,276  |            |                |                  |                |                 |   
| [Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding](https://doi.org/10.1073/pnas.1613231114)  |             | 4,276   |            |                |                  |                |                 |   
| [High-Throughput Machine Learning-Aided Antibody Discovery for Cell Surface Antigens](https://doi.org/10.1101/2025.05.15.650607)                                                      |             |   697   |            |                |                  |                |                 |  
| [Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space](https://doi.org/10.1038/s41467-022-31457-3)|             |   444   |            |                |       126        |                |                 |  
| [An integrated technology for quantitative wide mutational scanning of human antibody Fab libraries](https://doi.org/10.1038/s41467-024-48072-z)                                      |    2,111    |         |            |                |                  |                |                 |  
| [Binding affinity landscapes constrain the evolution of broadly neutralizing anti-influenza antibodies](https://doi.org/10.7554/elife.71393)                                          |             | 67,035  |            |                |                  |                |                 |   
| [Ab-CoV: a curated database for binding affinity and neutralization profiles of coronavirus-related antibodies](https://doi.org/10.1093/bioinformatics/btac439)                       |             |   568   |            |                |                  |                |                 |  
| [Automated optimisation of solubility and conformational stability of antibodies and proteins](https://doi.org/10.1038/s41467-023-37668-6)                                            |             |   19    |            |                |                  |        38      |        19       |  
| [IgDesign: In vitro validated antibody design against multiple therapeutic antigens using inverse folding](https://doi.org/10.1101/2023.12.08.570889)                                 |             |   321   |            |                |                  |                |                 |  
| [Unsupervised evolution of protein and antibody complexes with a structure-informed language model](https://doi.org/10.1126/science.adk8946)                                          |             |   224   |            |                |                  |       39       |                 |  
| [AVIDa-hIL6: A Large-Scale VHH Dataset Produced from an Immunized Alpaca for Predicting Antigen-Antibody Interactions](https://doi.org/10.48550/arXiv.2306.03329)                     |             | 573,892 |            |                |                  |                |                 |  
| [A SARS-CoV-2 Interaction Dataset and VHH Sequence Corpus for Antibody Language Models](https://doi.org/10.48550/arXiv.2405.18749)                                                    |             |  77,004 |            |                |                  |                |                 |   
| [Optimizing antibody affinity and stability by the automated design of the variable light-heavy chain interfaces](https://doi.org/10.1371/journal.pcbi.1007207)                       |             |  2,049  |            |                |                  |                |                 |   
| [Antibody evolution constrains conformational heterogeneity by tailoring protein dynamics](https://doi.org/10.1073/pnas.0603282103)                                                   |             |  21     |            |                |                  |                |                 |   
| [Measuring the sequence-affinity landscape of antibodies with massively parallel titration curves](https://doi.org/10.7554/eLife.23156)                                               |             | 11,067  |   10,970   |                |                  |                |                 |  
| [Humanization of antibodies using a machine learning approach on large-scale repertoire data](https://doi.org/10.1093/bioinformatics/btab434)                                         |             |         |            |      217       |                  |                |                 |   
| [Identifying developability risks for clinical progression of antibodies using high-throughput in vitro and in silico approaches](https://doi.org/10.1080/19420862.2023.2200540)      |             |         |            |                |       132        |     1,022      |                 |  
| [Assisted Design of Antibody and Protein Therapeutics (ADAPT)](https://doi.org/10.1371/journal.pone.0181490)                                                                          |             |         |            |                |                  |                |        33       |  
| [NbThermo: a new thermostability database for nanobodies ](https://doi.org/10.1093/database/baad021)                                                                                  |             |         |            |                |                  |                |       673       |   

